The Gulf Cooperation Council (GCC) has ambitious plans for the medtech and pharma sector, aiming to capitalize on growing demand across the region. After a volatile 2024, the first half of 2025 has been relatively stable, supported by stronger oil prices and easing inflation, allowing investors to re-focus on long-term opportunities. Among the sectors gaining attention are medical technology and pharmaceuticals, areas that hold immense potential to reshape healthcare in the Middle East. Demand for innovative treatments, lifestyle medicine, and advanced monitoring devices is rising, driven by chronic health conditions such as diabetes and obesity. However, while the opportunity is evident, progress remains slower than anticipated due to regulatory complexities, talent shortages, and fragmented infrastructure.
The GCC’s medtech sector is currently valued at $15–20 billion and has grown at a modest pace of about 5–6% over the past decade. Analysts project it could grow at around 7% annually in the coming years, fueled by aging populations, mandatory health insurance, and privatization of healthcare systems. Yet, despite these favorable conditions, the sector has not seen the level of investment or innovation that its potential suggests. According to Marwan El Hachem, Partner at Bain & Company, regulatory hurdles, lengthy approval processes, and centralized procurement practices that limit flexibility are major obstacles. Additionally, local human capital requires significant upskilling to meet the technical demands of a rapidly evolving industry. This has slowed momentum even as global companies show interest in tapping into the region’s large patient base.
Pharma companies in the region face similar constraints. Regulations remain fragmented, intellectual property enforcement is limited, and research and development infrastructure is underdeveloped. Dr. Basem Albarahmeh, General Manager of Globalpharma, highlights that scarce specialist talent and insufficiently integrated health data systems are major barriers to digital innovation. Yet, governments in the GCC are taking steps to address these issues, launching ambitious healthcare transformation programs such as Saudi Arabia’s Health Sector Transformation Program and the UAE’s Centennial 2071 plan. Both focus on enhancing healthcare infrastructure and driving localization of production. The pandemic further reinforced the urgency of reducing dependency on global imports, pushing governments to prioritize local manufacturing of vaccines, biosimilars, and essential medicines.
Localization has emerged as a cornerstone of regional strategy, with countries like Saudi Arabia and the UAE making significant investments. Saudi Arabia now hosts over 200 pharmaceutical and medical equipment facilities and has committed nearly $3 billion to expand its local capacity. A major milestone came through a Public Investment Fund-backed partnership with Novo Nordisk to localize insulin production, with plans to extend into GLP-1 drugs and advanced biotherapeutics. The UAE has also encouraged partnerships, with Mubadala increasing investments in life sciences and Abu Dhabi collaborating with Cleveland Clinic to advance precision medicine. Local manufacturers like Globalpharma are forging joint ventures with international players to anchor production, transfer knowledge, and expand access to regional markets. These efforts not only strengthen health security but also create skilled jobs and foster domestic research capabilities.
Experts believe that with sustained policy reforms and investment in R&D, the GCC could see strong growth in diagnostics, imaging, robotics, and remote monitoring devices. Government initiatives, combined with sovereign wealth fund backing, are gradually unlocking opportunities for innovation and collaboration. Yet, to achieve its full potential, the sector must overcome regulatory bottlenecks and build a skilled workforce capable of supporting advanced medical and pharmaceutical industries. If these hurdles are addressed, the GCC medtech-pharma ecosystem could emerge as a competitive force globally while meeting pressing regional healthcare needs.
Follow the SPIN IDG WhatsApp Channel for updates across the Smart Pakistan Insights Network covering all of Pakistan’s technology ecosystem.
